From FDA to NMPA: How Global Drug Regulatory Systems Are Fighting the Spread of Counterfeit Medicines

Explore how the FDA, China's NMPA, and the European Union are strengthening pharmaceutical regulation through digital traceability, supply chain security, and anti-counterfeit technologies to protect patients worldwide.

Top Stories

What Increases the Risk of Brain Tumors? Understanding the Main Risk Factors
Why Does the Epstein-Barr Virus Cause Nasopharyngeal Carcinoma? Understanding High-Risk Factors and Early Warning Signs

Latest Coverage

Counterfeit PD-1 Drugs Are Increasing: How Can Patients Identify Legitimate Pharmaceutical Channels?
In recent years, PD-1/PD-L1 immunotherapy has rapidly transformed cancer treatment worldwide and become an important ...
Why Are More Cancer Drugs Becoming Oral Therapies? The Current Landscape of Oral Targeted Therapy in China
Over the past two decades, the global oncology treatment landscape has undergone a major transformation. Traditional ...
Follicular Lymphoma Treatment Enters the Immunotherapy Era: Bispecific Antibodies Are Rising
Follicular lymphoma (FL) is one of the most common indolent B-cell non-Hodgkin lymphomas.
Which GBM Patients May Benefit from Bevacizumab?
Glioblastoma (GBM) is one of the most aggressive primary brain tumors, characterized by rapid growth, extensive infil...
A Milestone for Targeted Protein Degradation: The World’s First PROTAC Drug Approved
On May 1, 2026, the U.S. Food and Drug Administration officially approved Vepdegestrant (trade name: Veppanu) for the...

In-Depth Analysis

From FDA to NMPA: How Global Drug Regulatory Systems Are Fighting the Spread of Counterfeit Medicines
What Increases the Risk of Brain Tumors? Understanding the Main Risk Factors
Why Does the Epstein-Barr Virus Cause Nasopharyngeal Carcinoma? Understanding High-Risk Factors and Early Warning Signs
Counterfeit PD-1 Drugs Are Increasing: How Can Patients Identify Legitimate Pharmaceutical Channels?
This site uses Just the Docs, a documentation theme for Jekyll.